Shilpa Medicare launches first branded generic anticancer drug; stock trades flat

The products are being manufactured and supplied from the state-of-the-art USFDA approved manufacturing facility, Shilpa Medicare said in an exchange filing.

from India Infoline News Service https://ift.tt/2VxQ3xJ